Amla: Therapies to treat diabetic complications (Cataracts)
Diabetes mellitus is recognised as a leading cause of new cases of blindness and currently there is no medical treatment to prevent it.
Amla Emblica officinalis (also known as Indian Gooseberry) has been used for thousands of years as a traditional preparation for the treatment of diabetes in humans.
The results of a study by Puppala et al, support the continued development of natural products such as β-glucogallin from Amla as a therapeutic lead in the development of novel therapies to treat diabetic complications such as cataracts.
Extracts from this plant have been shown to be efficacious against the progression of cataract in diabetic model systems.